Article Text
Summary
Accidental long-term dabigatran etexilate inhalation was associated with subtherapeutic dabigatran serum concentrations in an elderly female patient with restrictive lung disease. A significant improvement in her pulmonary function was noted without other therapy directed towards her bronchopulmonary disease.
- cardiovascular system
- unwanted effects / adverse reactions
- interstitial lung disease
- arrhythmias
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Contributors VP and KJE have contributed to the data collection, data interpretation and manuscript writing of the current case report.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests VP has received honorary fees from Boehringer ingelheim, Pfitzer, BMS.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.